(Meryl Nass, M.D.) On Aug. 23, the U.S. Food and Drug Administration (FDA) issued its approval (also known as a license) for Pfizer’s Comirnaty COVID vaccine. The FDA documents related to the vaccine’s approval are as difficult to understand as the new brand name is to pronounce.